Cramer’s lightning round: I think Tesla is a decent situation

Cramer’s lightning round: I think Tesla is a decent situation


Ring Energy: “This is a small cap. It’s not a dice roll because it’s a legitimate company. I do prefer something that gives you that dividend because you know in the Investing Club, we bought Coterra. See, that is the better one. It’s got a good yield, 50% oil, 50% natural gas. … Coterra is the one to buy.”

Lantheus Holdings: “I was going to hit you with Danaher. That’s an Investing Club name. But I think that Lantheus is a really good idea.”

Kyndryl Holdings: “It’s an IBM reseller. I know that [CEO] Martin Schroeter would say it’s a lot more than that, but I’ve got to be conscious of the fact that the stock has not been that good. However, the stock does seem to be bottoming, and I think that Martin is shrewd enough to be able to take out some costs and get this thing rolling. So, $9 stock. It was up big today. It was up almost 10%. If it comes down a little, maybe you [take a little position].”

Antero Resources: “Antero is very, very cheap. I am saying … that Coterra has got that combination of dividend and growth that I like. It was misinterpreted on Friday when they reported. But Antero is very inexpensive, and I’m not going to say anything bad about it.”

Tesla: “Tesla has got the worst chart I’ve ever seen, and that’s what’s driving things. I am still a believer. People are very worried that [CEO Elon Musk] has to sell a lot of Tesla in order to be able to pay whatever he has to pay for Twitter. I say that Tesla is not cheap, but I’m not going to let the chart determine the fact that I think it’s a decent situation.”

Cramer's lightning round: I think Tesla is a decent situation

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More